| RS186494101 |
LRP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Donnai-Barrow syndrome, Donnai-Barrow syndrome |
| RS186495252 |
PSEN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1U, Alzheimer disease 3 |
| RS1864965277 |
CDH23
|
Health Risk |
Pathogenic |
— |
| RS1864965345 |
CDH23
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS186497293 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS186499459 |
EYS
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa 25, EYS-related disorder |
| RS186504463 |
MAN1B1
|
Health Risk |
Conflicting classifications of pathogenicity |
Rafiq syndrome, Inborn genetic diseases |
| RS1865048329 |
DYNC2H1
|
Health Risk |
Pathogenic/Likely pathogenic |
Jeune thoracic dystrophy, Asphyxiating thoracic dystrophy 3 |
| RS186505065 |
CIT
|
Health Risk |
Conflicting classifications of pathogenicity |
CIT-related disorder, CIT-related disorder |
| RS186506382 |
SACS
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Charlevoix-Saguenay spastic ataxia |
| RS186509771 |
VANGL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Sacral defect with anterior meningocele, Neural tube defect |
| RS186510389 |
SMC1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital muscular hypertrophy-cerebral syndrome, Congenital muscular hypertrophy-cerebral syndrome |
| RS186512876 |
COG5
|
Health Risk |
Pathogenic |
COG5-congenital disorder of glycosylation, COG5-congenital disorder of glycosylation |
| RS1865145294 |
CDH23
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1865149889 |
CDH23
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS186517232 |
QRICH2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS186519521 |
TG
|
Health Risk |
Conflicting classifications of pathogenicity |
Iodotyrosyl coupling defect, Iodotyrosyl coupling defect |
| RS186526524 |
HARS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 3B, Usher syndrome type 3B |
| RS186528086 |
ATL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 3A, ATL1-related disorder |
| RS1865287034 |
CDH23
|
Health Risk |
Pathogenic |
— |
| RS186530498 |
TMEM43
|
Health Risk |
Conflicting classifications of pathogenicity |
Arrhythmogenic right ventricular dysplasia 5, Cardiovascular phenotype |
| RS186530606 |
CEP135
|
Health Risk |
Pathogenic |
Microcephaly 8, primary |
| RS186533442 |
ANO5
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2L, Gnathodiaphyseal dysplasia |
| RS186535459 |
NEXMIF
|
Health Risk |
Conflicting classifications of pathogenicity |
NEXMIF-related disorder, NEXMIF-related disorder |
| RS186535521 |
PGAP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia, Hereditary spastic paraplegia |
| RS186535951 |
DNAH11
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS186538122 |
CACNA1S
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypokalemic periodic paralysis, type 1 |
| RS186538779 |
LAMA2
|
Health Risk |
Pathogenic |
Merosin deficient congenital muscular dystrophy, LAMA2-related muscular dystrophy |
| RS186544610 |
BEST1
|
Health Risk |
Pathogenic/Likely pathogenic |
Vitelliform macular dystrophy 2, Autosomal recessive bestrophinopathy |
| RS186544754 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, familial |
| RS186547381 |
FUS
|
Health Risk |
Conflicting classifications of pathogenicity |
Tremor, hereditary essential |
| RS186548567 |
LAMB1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS186548927 |
CDH23
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 12, Usher syndrome type 1D |
| RS186558364 |
ALDH7A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Pyridoxine-dependent epilepsy, Pyridoxine-dependent epilepsy |
| RS186559420 |
MYSM1
|
Health Risk |
Conflicting classifications of pathogenicity |
MYSM1-related disorder, Inborn genetic diseases |
| RS1865609793 |
CDH23
|
Health Risk |
Pathogenic/Likely pathogenic |
Usher syndrome type 1D, Pituitary adenoma 5 |
| RS1865621296 |
SDHD
|
Health Risk |
Likely pathogenic |
Carney-Stratakis syndrome, Pheochromocytoma |
| RS1865634253 |
CDH23
|
Health Risk |
Pathogenic |
— |
| RS186563991 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-onset myopathy with fatal cardiomyopathy, Myopathy |
| RS1865650219 |
SDHD
|
Health Risk |
Conflicting classifications of pathogenicity |
Carney-Stratakis syndrome, Paragangliomas with sensorineural hearing loss |
| RS1865653068 |
SDHD
|
Health Risk |
Conflicting classifications of pathogenicity |
Carney-Stratakis syndrome, Cowden syndrome 3 |
| RS1865654197 |
SDHD
|
Health Risk |
Pathogenic/Likely pathogenic |
Paragangliomas with sensorineural hearing loss, Pheochromocytoma |
| RS1865655347 |
SDHD
|
Health Risk |
Pathogenic |
Carney-Stratakis syndrome, Paragangliomas with sensorineural hearing loss |
| RS1865655722 |
SDHD
|
Health Risk |
Pathogenic |
Carney-Stratakis syndrome, Paragangliomas with sensorineural hearing loss |
| RS1865657237 |
SDHD
|
Health Risk |
Conflicting classifications of pathogenicity |
Carney-Stratakis syndrome, Paragangliomas with sensorineural hearing loss |
| RS1865684964 |
SDHD
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary pheochromocytoma and paraganglioma, Carney-Stratakis syndrome |
| RS1865686266 |
SDHD
|
Health Risk |
Pathogenic |
Carney-Stratakis syndrome, Pheochromocytoma |
| RS1865690107 |
SDHD
|
Health Risk |
Likely pathogenic |
Hereditary pheochromocytoma and paraganglioma, Hereditary pheochromocytoma and paraganglioma |
| RS1865721642 |
CDH23
|
Health Risk |
Pathogenic |
— |
| RS1865725846 |
AIP
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1865727404 |
CDH23
|
Health Risk |
Pathogenic |
— |
| RS1865731567 |
CDH23
|
Health Risk |
Pathogenic |
— |
| RS186577215 |
PMS2
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS186577948 |
KMT2D
|
Health Risk |
Pathogenic |
Kabuki syndrome, Kabuki syndrome 1 |
| RS1865794708 |
BTG4
|
Health Risk |
Pathogenic |
Oocyte maturation defect 8, Oocyte maturation defect 8 |
| RS1865805899 |
AIP
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Somatotroph adenoma |
| RS1865810132 |
CDH23
|
Health Risk |
Likely pathogenic |
Pituitary adenoma 5, multiple types |
| RS1865817808 |
GRIN2B
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal dominant 6 |
| RS1865820132 |
GRIN2B
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal dominant 6 |
| RS1865848848 |
AIP
|
Health Risk |
Likely pathogenic |
— |
| RS1865853604 |
AIP
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1865878972 |
AIP
|
Health Risk |
Pathogenic |
— |
| RS1865879702 |
BTG4
|
Health Risk |
Likely pathogenic |
Oocyte maturation defect 8, Oocyte maturation defect 8 |
| RS1865886567 |
BTG4
|
Health Risk |
Likely pathogenic |
Oocyte maturation defect 8, Oocyte maturation defect 8 |
| RS1865887896 |
CDH23
|
Health Risk |
Likely pathogenic |
Childhood onset hearing loss, Childhood onset hearing loss |
| RS186589083 |
CHRNG
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive multiple pterygium syndrome, Lethal multiple pterygium syndrome |
| RS186594769 |
CHIT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Chitotriosidase deficiency, Chitotriosidase deficiency |
| RS186595127 |
TECPR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 49, Hereditary spastic paraplegia |
| RS186595817 |
SPTA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Elliptocytosis 2, Pyropoikilocytosis |
| RS186600513 |
CACNA1E
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1866056028 |
ETV6
|
Health Risk |
Likely pathogenic |
— |
| RS1866073268 |
MICU1
|
Health Risk |
Likely pathogenic |
— |
| RS1866078752 |
CCDC82
|
Health Risk |
Pathogenic |
— |
| RS1866090527 |
CCDC82
|
Health Risk |
Likely pathogenic |
Intellectual disability, Intellectual disability |
| RS1866200282 |
RELT
|
Health Risk |
Pathogenic |
Amelogenesis imperfecta, type 3C |
| RS186620158 |
TRIOBP
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 28, Autosomal recessive nonsyndromic hearing loss 28 |
| RS1866204293 |
DYNC2H1
|
Health Risk |
Pathogenic/Likely pathogenic |
Jeune thoracic dystrophy, Asphyxiating thoracic dystrophy 3 |
| RS186620709 |
TPO
|
Health Risk |
Pathogenic/Likely pathogenic |
Deficiency of iodide peroxidase, Deficiency of iodide peroxidase |
| RS186624523 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiomyopathy |
| RS186631992 |
CACNA2D2
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-infantile DEE, Early-infantile DEE |
| RS186634083 |
LAMC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Occipital pachygyria and polymicrogyria, Occipital pachygyria and polymicrogyria |
| RS186634115 |
ABCC8
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary hyperinsulinism, Maturity-onset diabetes of the young |
| RS186641344 |
FANCG
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Ovarian cancer |
| RS186641437 |
APC
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hepatocellular carcinoma |
| RS186643840 |
MAK
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa 62 |
| RS186644871 |
MYO7A
|
Health Risk |
Likely pathogenic |
Autosomal dominant nonsyndromic hearing loss 11, MYO7A-related disorder |
| RS186649954 |
NTRK1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary insensitivity to pain with anhidrosis, Hereditary insensitivity to pain with anhidrosis |
| RS186652746 |
SYNE2
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 5, autosomal dominant |
| RS1866558759 |
CBLIF
|
Health Risk |
Pathogenic |
Hereditary intrinsic factor deficiency, Hereditary intrinsic factor deficiency |
| RS186663314 |
MECP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Severe neonatal-onset encephalopathy with microcephaly, MECP2-related disorder |
| RS186663906 |
ASPM
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephaly 5, primary |
| RS1866696179 |
CDH23
|
Health Risk |
Pathogenic |
— |
| RS1866696630 |
CDH23
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS186669805 |
PCSK9
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, familial |
| RS186670730 |
KMT2D
|
Health Risk |
Conflicting classifications of pathogenicity |
Kabuki syndrome 1, Kabuki syndrome |
| RS186672543 |
ILDR1
|
Health Risk |
Conflicting classifications of pathogenicity |
ILDR1-related disorder, ILDR1-related disorder |
| RS186681106 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-onset myopathy with fatal cardiomyopathy, Dilated cardiomyopathy 1G |
| RS186684627 |
IFITM5
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS186685101 |
CEP41
|
Health Risk |
Conflicting classifications of pathogenicity |
Joubert syndrome 15, Joubert syndrome 15 |
| RS186686151 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, Nemaline myopathy 2 |